Back to search

Article

Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stress

2025-09-04

Abstract excerpt

<title>Abstract</title> <p>Peripherally restricted cannabinoid CB1 receptor antagonists without central side effects hold promise for treating metabolic disorders including diabetes and obesity. In atherosclerosis, the specific effects of peripheral endothelial CB1 signaling remain incompletely understood. Here, we report the expression of the CB1 encoding gene CNR1 in arterial endothelial cells of human plaques....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a5738917-a003-54c4-9857-4756cacfce9c
DOI
10.21203/rs.3.rs-6944788/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stressDOI 10.21203/rs.3.rs-6944788/v1
Select a neighboring publication to make it the new centre.